1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism.
- 1 September 1983
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 80 (18) , 5583-5587
- https://doi.org/10.1073/pnas.80.18.5583
Abstract
Extensive fusion was induced in mouse alveolar macrophages by treatment with conditioned media obtained from spleen cell cultures treated with 15 .mu.g of phytohemagglutinin or concanavalin A/ml or with 12 nM 1.alpha.,25-dihydroxyvitamin D3 [1.alpha.,25(OH2)D3]. The fusion rate was 80-90% on day 3. In addition, 1.alpha.,25(OH)2D3 added directly to alveolar macrophages induced fusion of about 35% of the cells on days 3, whereas direct addition of phytohemagglutinin and concanavalin A did not enhance fusion at all. When conditioned media from spleen cell or T cell cultures treated with 12 nM 1.alpha.,25(OH)2D3 were applied to a Sephadex G-100 column, a fusion factor (MW 37,000-70,000) could be separated from 1.alpha.,25(OH)2D3. 1.alpha.,25(OH)2D3 induced fusion at 0.012-120 nM in a dose-dependent manner both by direct action and by spleen cell-mediated indirect action, but the fusion rate was always much greater in the latter than in the former at each concentration of the vitamin. Of the vitamin D3 derivatives tested, 1.alpha.,25(OH)2D3 was the most potent, followed successively by 1.alpha.,24R,25-trihydroxyvitamin D3, 1.alpha.-hydroxyvitamin D3, 25-hydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3. 1.alpha.,25(OH)2D3 induces fusion of mouse alveolar macrophages by both a direct and an indirect mechanism, the latter mediated by spleen cells, probably by T cells.This publication has 30 references indexed in Scilit:
- In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes.The Journal of Experimental Medicine, 1982
- Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes.The Journal of Experimental Medicine, 1982
- Contact-Mediated Bone Resorption by Human Monocytes in VitroScience, 1978
- Big and Little Forms of Osteoclast Activating FactorJournal of Clinical Investigation, 1977
- Production of osteoclast‐activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytesEuropean Journal of Immunology, 1976
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- Partial Purification of Osteoclast-Activating Factor from Phytohemagglutinin-Stimulated Human LeukocytesJournal of Clinical Investigation, 1974
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973
- CHARACTERIZATION OF A LYMPHOCYTE FACTOR WHICH ALTERS MACROPHAGE FUNCTIONSThe Journal of Experimental Medicine, 1973
- 1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue CultureScience, 1972